|3Jun 26, 8:08 PM ET

Casdin Amplify Fund, LP 3

3 · STANDARD BIOTOOLS INC. · Filed Jun 26, 2024

Insider Transaction Report

Form 3
Period: 2024-06-18
Holdings
  • Common Stock

    (indirect: See footnote)
    545,000
Footnotes (1)
  • [F1]The securities are owned directly by Casdin Amplify Fund, LP ("Amplify") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Amplify ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of Amplify (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.

Documents

1 file
  • 3
    ownership.xmlPrimary